Remove Bioinformatics Remove Licensing Remove Pharma Companies Remove Regulation
article thumbnail

Can technology help diversify clinical trials?

pharmaphorum

data processing systems that support bioinformatics modelling) and digital record systems (e.g. Once stakeholders are confident that technologies are adequately validated, selection based on scientific and ethical considerations can be presented to regulators in accordance with applicable legal and regulatory frameworks.

article thumbnail

Country focus: Hungary carves out a niche in digital pharma

pharmaphorum

They go into bioinformatics”. In the past couple of years, Turbine worked with a number of big pharma companies, including Bayer, and has also started building its own pipeline, including a target delivering new biological insight in PARP inhibitor resistance. “We They go into bioinformatics.”. So what do they do?

article thumbnail

GSK’s Maria Reyes Boceta-Muñoz Talks Vaccine Development in a Post-Pandemic World

XTalks

Investigation of the possibility of VAED is crucial during clinical trials for decision-making on vaccine licensing by regulatory agencies. To address cultural considerations, it is essential that pharma companies work together with healthcare providers to promote trust in vaccines.